发明申请
US20070274949A1 Cd25 Dna Vaccines for Treating and Preventing T-Cell Mediated Diseases
审中-公开
用于治疗和预防T细胞介导的疾病的Cd25 Dna疫苗
- 专利标题: Cd25 Dna Vaccines for Treating and Preventing T-Cell Mediated Diseases
- 专利标题(中): 用于治疗和预防T细胞介导的疾病的Cd25 Dna疫苗
-
申请号: US10591558申请日: 2007-06-08
-
公开(公告)号: US20070274949A1公开(公告)日: 2007-11-29
- 发明人: Irun Cohen , Avishai Mimran , Francisco Quintana , Felix Mor , Pnina Carmi
- 申请人: Irun Cohen , Avishai Mimran , Francisco Quintana , Felix Mor , Pnina Carmi
- 申请人地址: IL Rehovot 76100
- 专利权人: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
- 当前专利权人: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
- 当前专利权人地址: IL Rehovot 76100
- 国际申请: PCT/IL05/00273 WO
- 主分类号: A61K48/00
- IPC分类号: A61K48/00 ; A61K9/127
摘要:
Compositions comprising nucleic acids encoding the α chain of IL-2 receptor (IL-2Ra, CD25), homologs and fragment thereof, are effective in the treatment and prevention of T cell mediated pathologies. Methods are provided for enhancing anti-ergotypic T cell activity in a subject in need thereof, and for treating or preventing T cell mediated pathologies, such as autoimmune disease, inflammatory diseases and graft rejection.
信息查询